271 related articles for article (PubMed ID: 27278553)
1. Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines.
Pilco-Ferreto N; Calaf GM
Int J Oncol; 2016 Aug; 49(2):753-62. PubMed ID: 27278553
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of metformin action in MCF-7 and MDA-MB-231 human breast cancer cells involves oxidative stress generation, DNA damage, and transforming growth factor β1 induction.
Marinello PC; da Silva TN; Panis C; Neves AF; Machado KL; Borges FH; Guarnier FA; Bernardes SS; de-Freitas-Junior JC; Morgado-Díaz JA; Luiz RC; Cecchini R; Cecchini AL
Tumour Biol; 2016 Apr; 37(4):5337-46. PubMed ID: 26561471
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic effect of noscapine in breast cancer cell lines.
Quisbert-Valenzuela EO; Calaf GM
Int J Oncol; 2016 Jun; 48(6):2666-74. PubMed ID: 27081867
[TBL] [Abstract][Full Text] [Related]
4. Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.
Cheng CC; Shi LH; Wang XJ; Wang SX; Wan XQ; Liu SR; Wang YF; Lu Z; Wang LH; Ding Y
Int J Oncol; 2018 Jul; 53(1):339-348. PubMed ID: 29750424
[TBL] [Abstract][Full Text] [Related]
5. Synergic Effects of Doxorubicin and Melatonin on Apoptosis and Mitochondrial Oxidative Stress in MCF-7 Breast Cancer Cells: Involvement of TRPV1 Channels.
Koşar PA; Nazıroğlu M; Övey İS; Çiğ B
J Membr Biol; 2016 Apr; 249(1-2):129-40. PubMed ID: 26525975
[TBL] [Abstract][Full Text] [Related]
6. Low-dose doxorubicin with carotenoids selectively alters redox status and upregulates oxidative stress-mediated apoptosis in breast cancer cells.
Vijay K; Sowmya PR; Arathi BP; Shilpa S; Shwetha HJ; Raju M; Baskaran V; Lakshminarayana R
Food Chem Toxicol; 2018 Aug; 118():675-690. PubMed ID: 29920287
[TBL] [Abstract][Full Text] [Related]
7. Dillenia suffruticosa dichloromethane root extract induced apoptosis towards MDA-MB-231 triple-negative breast cancer cells.
Foo JB; Saiful Yazan L; Tor YS; Wibowo A; Ismail N; Armania N; Cheah YK; Abdullah R
J Ethnopharmacol; 2016 Jul; 187():195-204. PubMed ID: 27131434
[TBL] [Abstract][Full Text] [Related]
8. Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance.
Robinson P; Kasembeli M; Bharadwaj U; Engineer N; Eckols KT; Tweardy DJ
Biomed Res Int; 2016; 2016():1959270. PubMed ID: 26981525
[TBL] [Abstract][Full Text] [Related]
9. Combination Treatment with EGFR Inhibitor and Doxorubicin Synergistically Inhibits Proliferation of MCF-7 Cells and MDA-MB-231 Triple-Negative Breast Cancer Cells In Vitro.
Abrahams B; Gerber A; Hiss DC
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474312
[TBL] [Abstract][Full Text] [Related]
10. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
[TBL] [Abstract][Full Text] [Related]
12. [Stellera chamaejasme against multidrug resistance of triple-negative breast cancer MDA-MB-231 cell through Nrf2].
Zeng R; Wang XX; Cui XH; Yang Q; Zhu XX; Wang YJ
Zhongguo Zhong Yao Za Zhi; 2024 Apr; 49(8):2222-2229. PubMed ID: 38812237
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis Inducing Activity of Rhinacanthin-C in Doxorubicin-Resistant Breast Cancer MCF-7 Cells.
Chaisit S; Jianmongkol S
Biol Pharm Bull; 2021; 44(9):1239-1246. PubMed ID: 34471052
[TBL] [Abstract][Full Text] [Related]
14. Bik subcellular localization in response to oxidative stress induced by chemotherapy, in Two different breast cancer cell lines and a Non-tumorigenic epithelial cell line.
Trejo-Vargas A; Hernández-Mercado E; Ordóñez-Razo RM; Lazzarini R; Arenas-Aranda DJ; Gutiérrez-Ruiz MC; Königsberg M; Luna-López A
J Appl Toxicol; 2015 Nov; 35(11):1262-70. PubMed ID: 26059411
[TBL] [Abstract][Full Text] [Related]
15. Boswellia ovalifoliolata abrogates ROS mediated NF-κB activation, causes apoptosis and chemosensitization in Triple Negative Breast Cancer cells.
Thummuri D; Jeengar MK; Shrivastava S; Areti A; Yerra VG; Yamjala S; Komirishetty P; Naidu VG; Kumar A; Sistla R
Environ Toxicol Pharmacol; 2014 Jul; 38(1):58-70. PubMed ID: 24908637
[TBL] [Abstract][Full Text] [Related]
16. RIP1K and RIP3K provoked by shikonin induce cell cycle arrest in the triple negative breast cancer cell line, MDA-MB-468: necroptosis as a desperate programmed suicide pathway.
Shahsavari Z; Karami-Tehrani F; Salami S; Ghasemzadeh M
Tumour Biol; 2016 Apr; 37(4):4479-91. PubMed ID: 26496737
[TBL] [Abstract][Full Text] [Related]
17. Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines.
Zoli W; Ulivi P; Tesei A; Fabbri F; Rosetti M; Maltoni R; Giunchi DC; Ricotti L; Brigliadori G; Vannini I; Amadori D
Breast Cancer Res; 2005; 7(5):R681-9. PubMed ID: 16168113
[TBL] [Abstract][Full Text] [Related]
18. Apoptotic activity of 5-fluorouracil in breast cancer cells transformed by low doses of ionizing α-particle radiation.
Ponce-Cusi R; Calaf GM
Int J Oncol; 2016 Feb; 48(2):774-82. PubMed ID: 26691280
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells.
Amornsupak K; Insawang T; Thuwajit P; O-Charoenrat P; Eccles SA; Thuwajit C
BMC Cancer; 2014 Dec; 14():955. PubMed ID: 25512109
[TBL] [Abstract][Full Text] [Related]
20. A diverse induction of apoptosis by trabectedin in MCF-7 (HER2-/ER+) and MDA-MB-453 (HER2+/ER-) breast cancer cells.
Atmaca H; Bozkurt E; Uzunoglu S; Uslu R; Karaca B
Toxicol Lett; 2013 Aug; 221(2):128-36. PubMed ID: 23792433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
